Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 35Colonic Neoplasms 14Colorectal Neoplasms 13Rectal Neoplasms 11Prostatic Neoplasms 11Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Endometrial Neoplasms 8Uterine Cervical Neoplasms 7Obesity 7Motor Activity 7Lung Neoplasms 7Overweight 6Depression 6Small Cell Lung Carcinoma 5Ovarian Neoplasms 5Fatigue 5Breast Carcinoma In Situ 5Anxiety Disorders 5Tobacco Use Disorder 4Sexuality 4Sexual Dysfunction, Physiological 4Pancreatic Neoplasms 4Leukemia, Myeloid, Acute 4Carcinoma, Intraductal, Noninfiltrating 4Urinary Bladder Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3

Interventions

Exercise 6Transcranial Direct Current Stimulation 4Walking 3Memantine 3Tablets 2Standard of Care 2Methods 2Donepezil 2Cognitive Behavioral Therapy 2mazdutide 1lithium sulfate 1lime 1fasudil 1enzalutamide 1blueberry extract 1beta Carotene 1acetaminophen, aspirin, caffeine drug combination 1XENP 1595 1Vitamin E 1Vitamin D 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Time 1Therapeutics 1Tai Ji 1Sugars 1Sodium Chloride 1Sirolimus 1Silymarin 1Riluzole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cognitive Dysfunction × Counseling × Clear all
NCT00884338 2009-12-21

Cognitive Function After Stem Cell Transplantation

Charite University, Berlin, Germany

Phase 3 Unknown
60 enrolled

Fatigue, Motor Activity, Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡